Clinical trial
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung…
NCT00265200 · University of Louisville, Other · Terminated
Key facts
| NCT number | NCT00265200 |
|---|---|
| Title | Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer |
| Official title | Bone Metabolic Markers, TRAP, and Zometa's Effect on Bone Metastasis Due to Lung Cancer |
| Lead sponsor | University of Louisville, Other |
| Collaborators | James Graham Brown Cancer Center Novartis Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small Cell Lung, Small Cell Lung, Metastases |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 28 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Dec 14, 2005 |
| Last update posted | Mar 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: